Cargando…
Circulating Biomarkers for Predicting Infliximab Response in Rheumatoid Arthritis: A Systematic Bioinformatics Analysis
BACKGROUND: Infliximab shows good efficacy in treating refractory rheumatoid arthritis (RA). However, many patients responded poorly and related studies were inconsistent in predictive biomarkers. This study aimed to identify circulating biomarkers for predicting infliximab response in RA. MATERIAL/...
Autores principales: | Huang, Qiu-lan, Zhou, Fu-jiang, Wu, Cheng-bin, Xu, Chao, Qian, Wen-ying, Fan, De-ping, Cai, Xu-shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404751/ https://www.ncbi.nlm.nih.gov/pubmed/28413214 http://dx.doi.org/10.12659/MSM.900897 |
Ejemplares similares
-
Oxaliplatin and Infliximab Combination Synergizes in Inducing Colon Cancer Regression
por: Li, Wenya, et al.
Publicado: (2017) -
Network Pharmacology to Identify the Pharmacological Mechanisms of a Traditional Chinese Medicine Derived from Trachelospermum jasminoides in Patients with Rheumatoid Arthritis
por: Jiang, Tao, et al.
Publicado: (2020) -
Identification of Hub Genes and Pathways in Gastric Adenocarcinoma Based on Bioinformatics Analysis
por: Qiu, Jieping, et al.
Publicado: (2020) -
Combination of Circulating miRNA-320a/b and D-Dimer Improves Diagnostic Accuracy in Deep Vein Thrombosis Patients
por: Jiang, Zhiyun, et al.
Publicado: (2018) -
Neutrophil-to-Platelet Ratio in Patients with Ulcerative Colitis Treated with Infliximab or Vedolizumab: A Retrospective, Single-Center Study in Poland
por: Warpechowski, Marcin, et al.
Publicado: (2023)